BLI - Banque de Luxembourg Investments
Source: SEC Form 13F · as of Mar 2026BLI - Banque de Luxembourg Investments holds 16 biotech & pharma companies tracked by BioSniper, totaling $257.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$257.9M
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 372,869 | $69.0M |
| IDXXIDEXX LABORATORIES INC /DE | 55,771 | $37.4M |
| ABTABBOTT LABORATORIES | 200,725 | $24.8M |
| JNJJOHNSON & JOHNSON | 109,599 | $22.3M |
| LLYELI LILLY & Co | 17,500 | $18.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 42,683 | $13.9M |
| WSTWest Pharmaceutical Services Inc. | 49,900 | $13.6M |
| BMYBRISTOL MYERS SQUIBB CO | 247,000 | $13.2M |
| IQVIQVIA Holdings Inc. | 55,825 | $12.5M |
| GMEDGlobus Medical Inc. | 136,500 | $11.8M |
| TECHBIO-TECHNE Corp | 198,100 | $11.5M |
| MRKMerck & Co., Inc. | 55,500 | $5.8M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 5,500 | $2.5M |
| AMGNAMGEN INC | 1,003 | $324K |
| ABBVAbbVie Inc. | 1,399 | $316K |
| GILDGILEAD SCIENCES, INC. | 2,531 | $307K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.